Biogen Inc. buy Royal Bank of Canada
Start price
09.02.26
/
50%
€167.00
Target price
09.02.27
€197.12
Performance (%)
3.08%
Price
15.07.26
€172.14
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 3.08%. This prediction currently runs until 09.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -1.803% | -1.803% |
| iShares Core DAX® | -0.097% | 0.537% |
| iShares Nasdaq 100 | 0.585% | -2.390% |
| iShares Nikkei 225® | -0.055% | -2.746% |
| iShares S&P 500 | 0.939% | 1.287% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its price target raised by analysts at Royal Bank Of Canada from $217.00 to $233.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat